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Mitochondrial energy production is a tightly regu-
lated process involving the coordinated transcription
of several genes, catalysis of a plethora of posttrans-
lationalmodifications, and the formation of very large
molecular supercomplexes. The regulation of mito-
chondrial activity is particularly important for the
brain, which is a high-energy-consuming organ that
depends on oxidative phosphorylation to generate
ATP. Here we show that brain mitochondrial ATP
production is controlled by the cytoplasmic polyade-
nylation-induced translation of an mRNA encoding
NDUFV2, a key mitochondrial protein. Knockout
mice lacking the Cytoplasmic Polyadenylation
Element Binding protein 1 (CPEB1) have brain-
specific dysfunctional mitochondria and reduced
ATP levels, which is due to defective polyadenyla-
tion-induced translation of electron transport chain
complex I protein NDUFV2 mRNA. This reduced
ATP results in defective dendrite morphogenesis of
hippocampal neurons both in vitro and in vivo. These
and other results demonstrate that CPEB1 control of
mitochondrial activity is essential for normal brain
development.
INTRODUCTION
Mitochondrial ATP production accounts for 90% of the energy
produced in mammalian cells, and thus the regulation of mito-
chondrial function is critically important for cell growth and
viability. Nuclear-encoded mitochondrial proteins are regulated
transcriptionally by various factors such as nuclear respiratory
factors NRF1 and NRF2, stimulatory protein 1 (Sp1), estrogen-
related receptor a (ERRa), and yin yang 1 transcription factor
(YY1) (Scarpulla, 2008). PGC1a plays a role in coordinating
the expression of mitochondrial subunits commensurate with
changes in the environment (Lin et al., 2005). Mitochondrial
activity is also regulated by the formation of supercomplexes
that allow for substrate channeling (Shoubridge, 2012). Post-
translational modifications affect mitochondrial function (Koc
and Koc, 2012), as does tissue-specific expression of different
mitochondrial proteins that generate unique mitochondrialCell Mdynamics to accommodate different requirements for a given
tissue (Pagliarini et al., 2008).
The cytoplasmic polyadenylation element binding proteins
(CPEBs) are a family of four RNA binding proteins that are widely
expressed in vertebrates (Mendez and Richter 2001). CPEB1 is
the founding member of this family; it associates with the cyto-
plasmic polyadenylation element (CPE), a U-rich (UUUUUAU)
structure generally residing within 100 bases of the AAUAAA
pre-mRNA cleavage and polyadenylation signal in the 30UTRs
of specific mRNAs. CPEB proteins 2–4 probably also associate
with U-rich structures (Novoa et al., 2010), but they do not
appear to recognize the CPE with the same high affinity as
CPEB1 (Huang et al., 2006). Although all CPEB proteins regulate
mRNA expression (Huang et al., 2006; Chen and Huang 2011;
Novoa et al., 2010; Wang and Huang 2012), CPEB1 is centrally
important for promoting translation by stimulating cytoplasmic
polyadenylation. CPEB1 is the key component of the cyto-
plasmic polyadenylation complex, which also includes cleavage
and polyadenylation specificity factor (CPSF), the noncanonical
poly(A) polymerase Gld2, the deadenylating enzyme PARN, the
scaffold protein symplekin, poly(A) binding protein (PABP), and
Maskin or Neuroguidin (Ngd), which also bind the cap-binding
factor eIF4E (Barnard et al., 2004; Kim and Richter 2006, 2007;
Richter 2007; Udagawa et al., 2012).When associatedwith these
factors in a large ribonucleoprotein (RNP) complex, CPE-con-
taining mRNAs have short poly(A) tails and are translationally
repressed. In response to an environmental cue, the kinase
Aurora A phosphorylates CPEB1, which causes the dissociation
of PARN from the RNP complex, resulting in default Gld2-cata-
lyzed polyadenylation (Mendez et al., 2000; Kim and Richter
2006). The newly elongated poly(A) tail then is bound by PABP,
which also binds the initiation factor eIF4G. eIF4G subsequently
displaces Maskin from eIF4E and thereby recruits other initiation
factors and the 40S ribosomal subunit to the 50 end of the mRNA
(Cao et al., 2006; Kim and Richter 2007).
CPEB1-mediated translation is required for several biological
phenomena including oocyte development (Tay and Richter
2001), neuronal synaptic plasticity and learning and memory
(Alarcon et al., 2004; Berger-Sweeney et al., 2006; Zearfoss
et al., 2008; Udagawa et al., 2012), cell growth (Groisman
et al., 2006; Burns and Richter 2008), and hepatic insulin resis-
tance (Alexandrov et al., 2012). Fibroblasts derived from
CPEB1 knockout (KO) mice bypass senescence, as do human
skin fibroblasts depleted of CPEB1 (Groisman et al., 2006; Burns
and Richter 2008); in both cell types, reduced p53 mRNA trans-
lation is a key event causing the immortalization (Burns andetabolism 16, 789–800, December 5, 2012 ª2012 Elsevier Inc. 789
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Figure 1. CPEB1 Controls Mitochondrial
ATP Production
(A) ATP levels in brain, liver, muscle, and hippo-
campal neurons from five WT and five CPEB1
KO mice.
(B) ATP in WT and CPEB1 KO hippocampal
neurons isolated from three different embryos in-
fected with lentiviruses expressing shRNA against
CPEB1 (CPEB1 KD), nonsilencing shRNA (NS), or
HA-tagged CPEB1 (CPEB1).
(C) Oxygen consumption in four WT and four
CPEB1 KO brain and cultured hippocampal
neurons with or without the inhibitors (inhi) rote-
none plus antimycin.
(D) Quasiquantitative PCR of mitochondrial (mt)
and tubulin DNAs in WT and CPEB1 KO brain.
(E) Western blots of the mitochondrial protein
cytochromecandactin inWTandCPEB1KObrain.
(F) Mitochondrial membrane potential as mea-
sured by TMRM in seven hippocampal neurons
each from eight WT and eight CPEB1 KO embryos
cultured for 2–20 DIV. *p < 0.05; **p < 0.01
Student’s t test, all experiments were done in
three replicates, the bars indicate SEM. See also
Figure S1.
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Translational Control of Energy BalanceRichter 2008; Groppo and Richter 2011). CPEB1 depletion, at
least in human fibroblasts, results in the Warburg effect, a
cancer-related phenomenon in which ATP production by mito-
chondrial oxidative phosphorylation is impaired but compen-
sated for by increased glycolysis (Burns and Richter 2008;
Levine and Puzio-Kuter 2010; Vander Heiden et al., 2009). The
reduced p53 levels in CPEB1-depleted cells lowers synthesis
of cytochrome c oxidase (SCO2), which in turn impairs electron
transport chain complex IV activity.
In this study, we sought to investigate whether CPEB1 defi-
ciency results in impairedmitochondrial function in animal tissue.
Surprisingly, we observed that in CPEB1 KO animals, mitochon-
drial energy productionwas reduced in the brain and neurons but
not muscle or liver and was unaccompanied by elevated glycol-
ysis as occurs in the Warburg effect. Further analysis showed
that the polyadenylation of electron transport chain complex I
protein NDUFV2 mRNA was compromised in neurons, which
caused reduced levels of the protein and hence inefficient
oxygen consumption and ATP production. As a consequence
of depressed ATP levels, dendrite morphogenesis was also
reduced in CPEB1-deficient hippocampal neurons both in vitro
and in vivo. Impaired dendrite branching and growth in CPEB1-790 Cell Metabolism 16, 789–800, December 5, 2012 ª2012 Elsevier Inc.deficient neurons was rescued when
normal levels of ATPwere restored. These
and other observations reveal an essen-
tial and unexpected role for translational
control in energy production in the brain.
RESULTS
CPEB1 Deficiency Leads to
Reduced Mitochondrial Function
To assess whether CPEB1 KO mice have
altered bioenergetics similar to CPEB1-depleted fibroblasts, ATP levels were measured in extracts
from brain, liver, and muscle. Although the latter two tissues
had no change in ATP concentration compared to wild-type
(WT), the brain displayed an 56% reduction, while cultured
hippocampal neurons derived from CPEB1 KO mice showed
a 32% reduction (Figure 1A). We measured the recovery of
ATP from brain lysates by titrating in known amounts of this
nucleoside triphosphate. Using our extraction procedure, there
was a 41% recovery of ATP from WT and a 50% recovery from
CPEB1 KO brain lysates; consequently, the values shown in
the figure reflect corrected values for the recovery of ATP. The
reduced ATP in CPEB1 KO brain may be contrasted to the effect
observed in human foreskin fibroblasts in which CPEB1 deple-
tion, while reducing mitochondrial ATP production, had no effect
on overall ATP levels because of a compensatory upregulation
of glycolysis. This phenomenon of reduced mitochondrial ATP
production and elevated glycolysis is known as the Warburg
effect and is a characteristic of cancer cells that may contribute
to malignant transformation (Vander Heiden et al., 2009; Dang,
2012). In the brain, normal levels of ATP were restored in the
CPEB1 KO neurons when they were infected with lentivirus ex-
pressing CPEB1-HA (Figure 1B), indicating that the depletion
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Figure 2. CPEB1 Regulates the Activity of
Electron Transport Chain Complex I
(A) Schematic of mitochondrial electron transport
chain complexes I–V.
(B–E) Activities of electron transport chain (ETC)
complexes I-IV in mitochondria from three WT and
three CPEB1 KO mouse brain.
(F) Oxygen consumption of mitochondria isolated
from WT or CPEB1 KO brains. Mitochondria were
incubated in a chamber containing an oxygen
sensor; oxygen consumption was measured in the
presence of complex I (malate plus glutamate) or
complex II substrates (succinate). ADP was added
to stimulate state 3 respiration. *p < 0.05; **p < 0.01
Student’s t test, three replicates, the bars indicate
SEM. See also Figure S2 and Table S1.
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Translational Control of Energy Balanceof ATP is reversible. Next, we determined whether shRNA
depletion of CPEB1 in WT neurons had a similar effect on ATP
generation. As shown in Figure S1A (available online), an
65% depletion of CPEB1 was accompanied by an 65%
reduction in ATP only upon shRNA depletion of this protein,
but not when a control nonsilencing (NS) shRNA was used (Fig-
ure 1B). These results show that CPEB1 controls energy balance
specifically in neurons.
To investigate how CPEB1 regulates ATP levels, oxygen
consumption was measured and shown to be reduced by
50% in CPEB1 KO brain as well as cultured CPEB1 KO hippo-
campal (Figure 1C) and cortical neurons (Figure S1B); oxygen
consumption in CPEB1 KO glia, however, was unchanged
(Figure S1C). Oxygen consumption in brain lysates and hippo-
campal neurons was also determined in the presence of
mitochondrial inhibitors rotenone plus antimycin and shown to
be completely inhibited, indicating that the oxygen consumption
we measured was entirely mitochondrial (Figure 1C). We also
found that oxygen consumption in brain lysates increased for
54 min, after which time it diminished. This nonlinear measure-
ment could be due to clumps of cells in the brain lysates that
might have incomplete access to nutrients and oxygen, thus
leading to the death of some of the neurons. Lactate production,
which indicates efficiency of glycolysis, was unaltered in CPEB1
KO brain or neurons (Figure S1D), demonstrating that the
reduction in ATP was not compensated by enhanced glycolysis.Cell Metabolism 16, 789–800,Mitochondrial levels as determined by
mitochondrial DNA (Figure 1D) and cyto-
chrome c content (Figure 1E) were
unchanged in neurons, indicating that an
alteration in the mass of mitochondria
was not responsible for reduced ATP
production in CPEB1-depleted neurons.
Mitochondrial morphology in WT and
CPEB1 KO neurons as determined
by confocal microscopic examination
of mitotracker-stained cells showed no
significant differences (Figure S1E), indi-
cating that the gross morphology of
mitochondria was unaffected by the
loss of CPEB1. However, mitochondrial
membrane potential as measured by thefluorescent dye tetramethylrhodamine methyl ester (TMRM)
was reduced by 40%–60% in DIV 2-20 cultured CPEB1 KO
neurons (Figure 1F). These data demonstrate that mitochondrial
function, but not mitochondrial mass, is reduced in CPEB1 KO
brain and neurons.
Mitochondrial Insufficiency Is Due to an Impairment of
Electron Transport Chain Complex I
The electron transport chain consists of four multiprotein com-
plexes that sequentially transfer electrons to generate a proton
gradient across the inner mitochondrial membrane, which is
utilized by ATP synthase to phosphorylate ADP to produce
ATP (Figure 2A). The actions of each of the complexes were
measured in mitochondria isolated from WT and CPEB1 KO
mouse brains. Because exogenous substrates were used for
the assays, each complex was not influenced by the activity of
any other. The activities of complexes I and II showed a statisti-
cally significant decline in the CPEB1 KOmitochondria; complex
I activity in particular was strongly reduced by 60% (Figures
2B–2E). Citrate synthase, which indicates mitochondrial func-
tion unrelated to electron transport, was similar in WT and
CPEB1 KO brain (Figure S2A). Complex I and II activities were
also determined by measuring oxygen consumption of isolated
respiring mitochondria using an oxygen electrode. Oxygen con-
sumption wasmeasured in the presence of complex I substrates
malate plus glutamate or succinate, a complex II substrate. AsDecember 5, 2012 ª2012 Elsevier Inc. 791
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Figure 3. CPEB1 Regulates the Expression of Complex I Protein NDUFV2
(A) Blue native PAGE-resolved intact ETC complexes frommitochondria isolated from three WT and three CPEB1 KO brains and selected proteins in complexes
I–V were analyzed by western blotting. Quantification is shown on the histogram.
(B) Western blots were probed for mitochondrial proteins from total lysates from threeWT and three CPEB1 KO brains. Quantification is shown on the histogram.
(C) Quantitative RT-PCR analysis of NDUFV2, NDUFS4, and tubulin mRNAs in three WT and three CPEB1 KO brains. *p < 0.05; **p < 0.01 Student’s t test, three
replicates, the bars indicate SEM.
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Translational Control of Energy Balanceshown in Figure 2F and Table S1, oxygen consumption in both
WT and CPEB1 KO mitochondria increased significantly upon
addition of mitochondria to the reaction mix. The rate of oxygen
consumption further increased upon addition of ADP (state 3
respiration). However, the rate of oxygen consumption was
lower in CPEB1 KO mitochondria in the presence of complex I
substrates but was unaffected in the presence of the complex
II substrate, again demonstrating that CPEB1 KO mitochondria
are defective for complex I activity.
Reactive oxygen species (ROS) were increased by 60 and
80% in the CPEB1 KO brain and neurons, respectively (Fig-
ure S2B). Complex I is a significant generator of ROS in mito-
chondria, which could explain why CPEB1 KO mitochondria
have increased ROS. To determine whether the increased ROS
leads to increased oxidative damage, the levels of protein
carbonyl groups were measured as an indicator of oxidative
damage. Carbonyl groups are produced on amino side chains
(especially of proline, arginine, lysine, and threonine) when they
are oxidized. As shown in Figure S2C, CPEB1 KO brain had
only very slightly elevated protein oxidative damage.
We next used blue native PAGE and western blotting to
examine specific proteins in each intact complex isolated from
WT and CPEB1 KO mitochondria. Because the blue native
PAGE is nondenaturing, the electron transport chain complexes792 Cell Metabolism 16, 789–800, December 5, 2012 ª2012 Elsevierremain intact and are not dissociated into their constituent
subunits. Figure 3A shows that in contrast to proteins in
complexes II, III, IV, and V, complex I was reduced by 40%
(as shown by blotting for its proteins NDUFV2 and NDUFA9) in
the CPEB1 KO mitochondria. Complex II was not affected in
the blue native PAGE analysis, but its activity was reduced by
about 20% in CPEB1 KO mitochondria (Figure 2C), suggesting
that the dysfunction in complex II is not due to the loss of
its constituent proteins. Examination of complex I proteins in
total brain extracts demonstrates a reduction, by 35%, only
of NDUFV2 in the CPEB1 KO samples (Figure 3B). NDUFV2
mRNA levels, however, were comparable in WT and CPEB1
KO brain (Figure 3C). These data suggest not only that reduced
NDUFV2 in CPEB1 KO mitochondria is responsible for impaired
ATP production but that the levels of this protein might also be
regulated at the posttranscriptional level.
Complex I Protein NDUFV2 Expression Is Reduced in
CPEB1 KO Mice
NDUFV2 is one of 14 core catalytic subunits of complex I; it
is synthesized in the cytoplasm and imported into mitochon-
dria via an amino-terminal mitochondrial targeting sequence
(MTS) (Figure 4A). To test whether reduced NDUFV2 in CPEB1
KO mitochondria is responsible for impaired ATP production,Inc.
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Figure 4. CPEB1 Regulates NDUFV2 mRNA Translation
(A) Schematic of NDUFV2 mRNA showing the mitochondrial targeting signal, polyadenylation hexanucleotide AAUAAA, and CPEs.
(B) ATP was measured in WT and CPEB1 KO hippocampal neurons infected with lentiviruses expressing NDUFV2, or a mutant NDUFV2 lacking the MTS or
NDUFS4.
(C) Complex I activity was measured in WT and CPEB1 KO hippocampal neurons infected with lentivirus expressing NDUFV2.
(D)WT hippocampal neurons were infectedwith lentivirus expressing HA-CPEB1. HA antibodywas used to coimmunoprecipitate CPEB1 followed by RT-PCR for
NDUFV2, NDUFS4, and GAPDH mRNAs.
(E)WT and CPEB1 KO hippocampal neurons were incubated with 35S-methionine followed by immunoprecipitation of NDUFV2 and analysis by SDS-PAGE.WCE
refers to whole cell extract. The histogram shows the quantification of immunoprecipitation.
(F) The coding region of Renilla luciferase was appended with the WT NDUFV2 30UTR or one that lacked the CPEs (30UTRmut) (see A). Plasmids encoding these
constructs as well as firefly luciferase to serve as a control were transfected into neurons and analyzed for luciferase activity 3 days later. The data are plotted as
the ratio of Renilla luciferase activity to firefly luciferase activity.
(G) A PCR-based polyadenylation assay was used to determine the poly(A) tails of NDUFV2 and tubulin mRNAs inWT andCPEB1 KObrain (primers a/dT anchor).
The internal primers (a/b) indicate the relative amount of RNA in each sample. *p < 0.05; **p < 0.01 Student’s t test, three replicates, the bars indicate SEM.
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Translational Control of Energy BalanceCPEB1 KO neurons were infected with lentiviruses expressing
NDUFV2, or as controls, NDUFV2 that lacks a MTS or NDUFS4.
Figure 4B shows that ATP levels were restored to nearly
WT levels by ectopic MTS-containing, but not MTS-lacking,
NDUFV2. ATP levels were unaffected by ectopic expression of
NDUFS4 (a complex I constituent whose levels were unchanged
in CPEB1 KO), suggesting that the effect on ATP in CPEB1 KO
neurons is specifically due to reduced NDUFV2 (Figure 4B).
Complex I activity in CPEB1 KO neurons was also restored to
nearly WT levels by ectopic expression of NDUFV2 (Figure 4C).
These results demonstrate that reduced NDUFV2 in CPEB1
KO neurons leads to deficient mitochondrial ATP production.
NDUFV2 mRNA contains 30UTR CPEs, which although down-
stream of the AAUAAA could still support cytoplasmic polyade-
nylation (Fox et al., 1989). Based on this observation, we thought
this mRNAmight be directly regulated by CPEB1. To assess this
possibility, WT neurons were infected with a lentivirus express-
ing CPEB1-HA, followed by HA immunoprecipitation and RT-
PCR analysis for coprecipitating RNAs. As shown in Figure 4D,
NDUFV2 mRNA was immunoprecipitated with CPEB1-HA, but
not when the cells were not transduced with CPEB1-HA (mock
IP). GAPDH and NDUFS4 mRNAs were not coprecipitated with
CPEB1-HA, indicating its specificity for NDUFV2.
The decrease in amount of NDUFV2 in CPEB1 KO brains (Fig-
ure 3B) could be due to decreased translation or increased
degradation. To determine whether the synthesis of NDUFV2 is
altered in CPEB1 KO neurons, cells were pulse labeled with
35S-methionine for 1 hr followed by immunoprecipitation with
NDUFV2 antibody. Because of the short incubation time, the
radiolabeled NDUFV2 reflects new synthesis but very little
degradation because protein destruction usually occurs over
several hours. Figure 4E shows that NDUFV2 was synthesized
40% less efficiently in CPEB1 KO compared to WT neurons,
suggesting that CPEB1 mediates the translation of NDUFV2
mRNA. To investigate this possibility further, neuronswere trans-
fected with plasmids encoding firefly luciferase mRNA (transfec-
tion control) and Renilla luciferase mRNA appended with the
NDUFV2 30UTR containing or lacking the CPEs (see Figure 4A).
When determined 3 days after transfection, the Renilla luciferase
activity was 25% higher when the reporter RNA contained the
30UTR CPEs (Figure 4F). These data indicate that the CPEs
promote the translation of NDUFV2 mRNA.
Finally, an examination of NDUFV2 mRNA shows that the
length of its poly(A) tail was reduced by 30 nt in CPEB1 KO
versus WT brain; the poly(A) tail of tubulin mRNA was similar in
each genotype (Figure 4G). Equal amounts of NDUFV2 and
tubulin mRNAs fromWT andCPEB1 KOwere used for the assay.
Taken together, the data in Figure 4 indicate that the control of
ATP levels in neurons by CPEB1 is mediated by polyadenylation
and translation of NDUFV2 mRNA.
Dendritic Branching Is Impaired in CPEB1 KO Mice
We surmised that reduced brain ATP in CPEB1 KO mice might
impair neuron growth and/or morphogenesis. To assess this
possibility, neurons fromWT andCPEB1 KOmice were immuno-
stained for tubulin and subjected to a Sholl analysis in which
concentric rings surrounding a neuron with the cell body in
the center are used to measure dendrite branching. Although
neurons from both genotypes appeared similar during the initial794 Cell Metabolism 16, 789–800, December 5, 2012 ª2012 Elsevierdays of culture, by day 5 (Figure 5A) the CPEB1 KO neurons
showed 16% fewer dendrite branches (Figure 5B); dendrite
length was also reduced by 19% (Figure 5C). This result is
similar to that observed byBestman andCline (2008), who exam-
ined the role of CPEB1 in dendrite morphogenesis using Xeno-
pus laevis optic tectal neurons. Dendrite branching was restored
when CPEB1 was ectopically expressed in the DIV5 CPEB1 KO
neurons following lentivirus infection (Figures S3A and S3B).
Moreover, reduced branching was observed in DIV5WT neurons
following shRNA-mediated CPEB1 depletion (Figures S3A and
S3B). These data demonstrate that CPEB1 controls dendrite
morphology.
To investigate whether reduced ATP production is causative
for diminished dendrite arborization, CPEB1 KO neurons were
cultured in medium containing phosphocreatine for 4 days
in vitro (DIV), which increased ATP levels to nearlyWT levels (Fig-
ure 5D) and dendrite branching to near WT levels (Figures 5E
and 5F). Treatment of WT neurons with phosphocreatine, which
donates a high-energy phosphate to ADP to produce ATP,
enhanced dendrite branching (Figures 5E and 5F). These results
indicate that inhibited dendrite development in CPEB1 KO
neurons is most likely due to impaired ATP generation.
To examine whether CPEB1 regulates dendrite extension
in vivo, retroviruses expressing GFP and a scrambled or
CPEB1-directed shRNA were injected into the dentate gyrus
(DGs) of 6- to 7-week-oldmice (Ge et al., 2006). Twoweeks post-
injection, the dividing DG neurons were analyzed by serial
sectioning and three-dimensional reconstruction of confocal
images of GFP-immunostained cells. Total dendrite length
and branching were reduced by more than 50% in the knock-
down (KD) compared to WT neurons (Figures 6A–6C). CPEB1
depletion also reduced dendritic branching complexity of the
neurons (Figure 6D). Injection of a second shRNA against
CPEB1 resulted in similar deficits in dendrite length and
branching (data not shown). Taken together, these data demon-
strate that CPEB1 mediates neuronal maturation in vitro and
in vivo.
To assess whether ectopic expression of NDUFV2 in neurons
rescues the reduction in dendrite morphology by CPEB1 deple-
tion in vivo, retroviruses expressing CPEB1 shRNA and NDUFV2
containing or lacking its MTS were injected into the DG as
was performed previously, followed by serial sectioning and
3D reconstruction of GFP-stained images. Figures 6E and 6F
show that dendrite branch number as well as dendritic length
were increased upon expression of NDUFV2 containing but not
lacking its MTS. The dendrite branching defect was also rescued
by ectopic expression of NDUFV2, but not NDUFS4 in CPEB1
KO neurons in culture (Figure 6G), thus reaffirming the impor-
tance of NDUFV2 and mitochondrial energy production in den-
drite branching.
Figure 7 shows a model that summarizes the data described
above. In WT neurons, CPEB1 is associated with the 30UTR
CPEs of NDUFV2 mRNA. At steady state or perhaps in response
to an environmental cue, CPEB1 promotes poly(A) tail growth
and translation of the mRNA, resulting in NDUFV2 protein import
into the inner mitochondrial membrane, where it is incorporated
into complex I, thereby increasing flow of electrons through the
electron transport chain, and finally ATP is generated.When neu-
rons are CPEB1 deficient, reduced NDUFV2 mRNA translationInc.
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Figure 5. CPEB1 and ATP Promote Dendritic Development
(A) Morphology of WT and CPEB1 KO hippocampal neurons immunostained for tubulin at different days of culture. Scale bar, 50 mm.
(B) Sholl analysis was performed on WT and CPEB1 KO neurons cultured for 5 days (n = 60 neurons from three mice).
(C) Dendrite length was determined for cultured WT and CPEB1 KO neurons (n = 50 dendrites of 14 neurons from three mice).
(D) WT and CPEB1 KO neurons were continuously supplemented with phosphocreatine followed by determination of ATP at DIV6.
(E) Morphology of DIV6 WT and CPEB1 KO neurons following treatment with phosphocreatine; they were immunostained for tubulin (scale bar, 50 mm).
(F) Sholl analysis was performed on WT and CPEB1 KO neurons cultured in phosphocreatine (n = 55 neurons from three mice). *p < 0.05, **p < 0.01 Student’s
t test, three replicates; the bars indicate SEM. See also Figure S3.
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synaptic connections and inhibited synapse efficacy (Alarcon
et al., 2004; Zearfoss et al., 2008).
DISCUSSION
Our studies show that in CPEB1 KO brain and neurons, deficient
polyadenylation-induced translation of the complex I component
NDUFV2 mRNA impairs mitochondrial ATP production, thus
demonstrating a role for translational control in mouse neuronal
bioenergetics. Why CPEB1 deficiency should inhibit ATP pro-
duction only in the brain is unclear, but neurons as well asCell Mgerm cells contain the greatest abundance of this protein, and
thus NDUFV2 mRNA may not be regulated in other tissues
because of a relative paucity of CPEB1. Complex I levels also
differ among tissues, which have different energy requirements
and sensitivities to defects in oxidative phosphorylation (Distel-
maier et al., 2009; Koopman et al., 2010; Kunz, 2003). Perhaps
the brain, which is the largest consumer of energy, may require
CPEB1 to stimulate ATP generation in response to stress or
synapse stimulation (Kann and Kovacs, 2007; Nicholls and
Budd, 2000). It is important to note that steady-state levels of
ATP are the result of both generation and consumption by cells.
Although our report demonstrates that CPEB1 controls ATPetabolism 16, 789–800, December 5, 2012 ª2012 Elsevier Inc. 795
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Figure 6. CPEB1 and NDUFV2 Control
Dendrite Morphology In Vivo
(A) Three-dimensional (3D) confocal image recon-
struction of dendrites from hippocampal dentate
gyrus (DG) neurons that were stereotactically in-
jected with retroviruses expressing GFP (control) or
GFP and CPEB1 shRNA (14 dpi) (scale bar, 20 mm).
(B andC) Quantification of total dendritic length and
branch number of dividing DG neurons.
(D) Sholl analysis of dendrite complexity of dividing
DG neurons (14 dpi) (n = 4–6 animals). *p < 0.05,
Student’s t test, three replicates; ##p < 0.01, three
replicates; the bars indicate SEM.
(E and F) Quantification of dendritic branch length
and number following stereotactic DG injection of
retroviruses expressing GFP and shRNA for CPEB1
plus either WT NDUFV2 or NDUFV2 that lacks its
mitochondrial targeting sequence (MTS) (n = 12
animals).
(G) Sholl analysis of tubulin immunostained WT,
CPEB1 KO, and CPEB1 KO hippocampal neu-
rons infected in vitro with lentiviruses expressing
NDUFV2 or as control NDUFS4.
The bars indicate SEM.
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Translational Control of Energy Balanceproduction by enhancing the translation of complex I protein
NDUFV2 mRNA, we cannot rule out a possible effect of CPEB1
on ATP consumption as well. The control of ATP production by
CPEB1 reported here contrasts to that which occurs during the
Warburg effect. In transformed cells, aerobic glycolysis is due
in part to aberrant splicing of pyruvate kinase; a predominant
embryonic isoform, PKM2, is produced instead of the adult
PKM1 form (David et al., 2010; Christofk et al., 2008). As a conse-
quence, conversion of phosphoenolpyruvate (PEP) to pyruvate is
reduced, limiting the amount of substrate for the tricarboxylic
acid cycle (TCA) but stimulating the amount available for glycol-
ysis (Chen et al., 2010).
Experiments using Xenopus oocytes demonstrated that
Aurora A-catalyzed CPEB1 phosphoryation is necessary to stim-
ulate very robust polyadenylation and translation (Mendez et al.,
2000; Barnard et al., 2004; Kim and Richter, 2006; Groisman
et al., 2002). In neurons, CPEB1 phosphorylation is also impor-796 Cell Metabolism 16, 789–800, December 5, 2012 ª2012 Elsevier Inc.tant for polyadenylation in response to
synaptic activity (Udagawa et al., 2012).
In these cases, CPEB1 responds to ex-
ternal signaling cues (hormones, synapse
stimulation) to promote the expression of
generally quiescent or at least inefficiently
translated mRNAs. This CPEB1-mediated
on-off switch for translation may not func-
tion in quite the same way for the polyade-
nylation of NDUFV2mRNA observed here.
That is, NDUFV2 would always be synthe-
sized at some basal rate, but its expres-
sion might be turned up at times when
ATP generation is particularly important,
such as when neurites respond to guid-
ance cues as they navigate to their final
destinations. Thus, CPEB1 may act more
like a rheostat to turn translation up ordown, rather than a switch to turn translation on or off. The rheo-
stat analogy may be similar to the case in MEFs or primary
human fibroblasts where CPEB1 controls the expression of
p53 in a relatively modest manner, although even a 50% change
in p53 mRNA translation results in large alterations in cell phys-
iology such as senescence bypass (Groisman et al., 2006; Burns
and Richter, 2008; Groppo and Richter, 2011).
The importance of CPEB1 phosphorylation for neurite out-
growth was suggested by experiments of Bestman and Cline
(2008, 2009), who electroporated a phosphorylation-defective
‘‘dominant-negative’’ CPEB1 into Xenopus tadpole optic tectal
neurons and observed reduced dendrite branching as well as
glutamatergic synaptic strength. These authors also showed
that antisense morpholinos directed to CPEB1 mRNA, which
would inhibit its translation, produced a similar effect. In this
same vein, Lin et al. (2009) demonstrated that a dominant-nega-
tive CPEB1 introduced into Xenopus retinal ganglion neurons
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Figure 7. Model for CPEB1 Control of
Energy Production in Neurons
CPEB1 associates with the 30UTR CPEs of
NDUFV2 mRNA in the cytoplasm of neurons.
This interaction promotes poly(A) tail growth
and translation of NDUFV2 mRNA, resulting in
mitochondrial import of NDUFV2 protein, its
incorporation into complex I, and elevated ATP
production. ATP in turn is necessary for promoting
neurite morphogenesis. In CPEB1 knockout (KO)
neurons, a short poly(A) tail of NDUFV2 mRNA
results in inefficient translation, which impedes
complex I assembly and the generation of ATP. As
a consequence, neurite outgrown is curtailed.
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Although neither study identified the mRNA substrate(s) whose
presumed reduced translation was responsible for the mor-
phological defects in the neurons transduced with the domi-
nant-negative CPEB1, our observations suggest that reduced
ATP production caused by impaired NDUFV2 mRNA translation
could be involved.
Because CPEB1 is transported to dendrites (Huang et al.,
2003) where it mediates polyadenylation (Udagawa et al.,
2012), we surmise that NDUFV2 mRNA polyadenylation and
translation also occur in dendrites and probably cell bodies as
well. Mitochondria are present at the base of dendritic spines
where their ATP production is important for synapse function
(Li et al., 2004). We envision that dendritic ATP is also important
for neurite outgrowth andmorphogenesis and that when neurons
are CPEB1 deficient, reduced NDUFV2 mRNA translation and
ATP production lead to neurite stunting and perhaps loss of
synaptic connections and inhibited synapse efficacy (Alarcon
et al., 2004; Zearfoss et al., 2008).Moreover, synapse stimulation
induces not only CPEB1-dependent polyadenylation (Udagawa
et al., 2012) but alterations in mitochondrial transport and locali-
zation as well (Chen and Chan, 2006). Thus, the CPEB1-medi-
ated increase in mitochondrial activity could be an additional
layer of stimulation-dependent regulation of ATP production.Cell Metabolism 16, 789–800, DMitochondrial dysfunction is linked to
several neurologic diseases including
Parkinson’s, Alzheimer’s, and Hunting-
ton’s diseases as well as amyotrophic
lateral sclerosis (Lin and Beal 2006).
Aberrant complex I in particular may be
causative for Leigh disease, a neurode-
generative disorder (Loeffen et al.,
1998), and a number of encephalopathies
such as seizures, brainstem lesions, and
dystonia (Distelmaier et al., 2009). These
observations suggest that CPEB1 KO
mice might also show signs of neurode-
generation elicited by impaired complex
I activity. Gross examination of the
CPEB1 KO mice shows no obvious signs
of this malady; however, neurodegenera-
tive diseases are progressive and may
become obvious only in older mice.
Consequently, further investigations arerequired to determine whether there is a neurodegenerative
consequence to CPEB1 deficiency. In any case, CPEB1 KO
mice display reduced complex I activity by only 50%, which
might be insufficient to cause obvious phenotypes such as those
noted above. On the other hand, CPEB1 depletion reduces den-
drite branching and development in the brain and alters synaptic
efficacy. Moreover, impaired mitochondrial function inhibits
dendrite spine density and synaptic plasticity (Li et al., 2004),
suggesting that in the case of CPEB1 KO mouse, defective
complex I could be responsible, at least in part, for a deficit in
hippocampal long-term potentiation and hippocampus-depen-
dent learning andmemory (Alarcon et al., 2004; Berger-Sweeney
et al., 2006).EXPERIMENTAL PROCEDURES
Animals, Neuron Culture, and Isolation of Mitochondria
WT and CPEB1 C57BL/6 KO mice (Tay and Richter, 2001) were maintained in
accordance with the Institutional Animal Care and Use Committee (IACUC) of
the University of Massachusetts Medical School.
The culture of primary hippocampal and cortical neurons was performed as
described (Huang and Richter, 2007) in neurobasal media (Invitrogen) contain-
ing B27 supplement (B27 media) and glutamine (1 mg/ml). Liver, muscle, and
brain were dissected from 1-month-old female mice, washed, and homoge-
nized in Krebs-Ringers bicarbonate buffer (125 mM NaCl, 1.4 mM KCl,ecember 5, 2012 ª2012 Elsevier Inc. 797
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1 mM CaCl2) containing 1% BSA. Protein concentrations were determined
using the BCA assay (Pierce). Mitochondria were isolated using a MITO-
ISO1 kit (Sigma) and following the manufacturer’s instructions.
ATP Determination
Fifty to 100 mg of brain lysate was used to measure ATP concentration using
the CellTiter-Glo Luminescent Cell Viability kit (Promega) in a 96-well format.
To measure ATP concentration in neurons, 60,000 cells were trypsinized
from the dish, washed, and resuspended in 100 ml Krebs-Ringers bicarbonate
buffer plus HEPES. The brain lysates and the cultured neuron lysates were ali-
quoted into 96-well plates and assayed according to manufacturer’s instruc-
tions. To measure the recovery of ATP from brain lysates, known amounts of
ATP (0.1, 1, 10, and 100 mM) were used to measure ATP bioluminescene using
the CellTiter-Glo method as above in the presence or absence ofWT or CPEB1
KO brain lysate. The recovery of ATP was calculated from these values.
Oxygen Consumption
To measure oxygen consumption in brain lysates, WT and CPEB1 KO mouse
brains were washed and homogenized in 1 ml Krebs-Ringers bicarbonate
buffer plus HEPES (125 mM NaCl, 1.4 mM KCl, 20 mM HEPES [pH 7.4],
5 mM NaHCO3, 1.2 mM MgSO4, 1.2 mM KH2,PO4, 1 mM CaCl2) containing
1% BSA. Fifty to 100 mg of protein from each lysate was aliquoted into a BD
Oxygen biosensor systems plate (BD Biosciences) in triplicate and assayed
on a SAFIRE multimode microplate spectrophotometer at 1 min intervals for
120 min at an excitation wavelength of 485 nm and emission wavelength of
630 nm. To measure oxygen consumption in neurons and glia, 80,000 cells
were washed, suspended in 200 ml Krebs-Ringers bicarbonate buffer, and
aliquoted onto a BD Oxygen Biosensor systems plate in triplicate and assayed
as described above. To measure nonmitochondrial oxygen consumption, the
brain lysates and neurons were treated with 1 mM rotenone plus 10 mM
antimycin.
Electron Transport Chain Enzyme Activities
Purified mitochondrial samples were freeze thawed three times before use in
enzyme analysis to enable access of the substrate to the inner mitochondrial
membrane. Enzyme activities were determined by adding exogenous sub-
strates of the respective complexes and measuring the rate of conversion to
product in isolatedmitochondria. All analyses were performed on an Ultraspec
2000 UV/visible spectrophotometer (Pharmacia Biotech) in triplicate. Specific
enzyme activities were calculated by subtracting the background activities
using inhibitors to the complexes.
Measurement of Mitochondrial Respiration
Mitochondria were isolated fromWT and CPEB1 KOmouse brain using differ-
ential centrifugation as described earlier. Oxygen consumption in the intact
mitochondria was measured using Clark-type oxygen-sensitive electrode
(YSI Incorporated). The assays were performed as described (Li and Graham,
2012).
Blue Native PAGE Electrophoresis
Mitochondria isolated from WT and CPEB1 KO mouse brain were resolved by
blue native (BN)-PAGE as described (Wittig et al., 2006) and immunoblotted for
mitochondrial proteins.
Translational Efficiency
DIV10 WT hippocampal neurons were cotransfected with 2 mg of pGL-3 and
2 mg of pRLTK-NDUFV2 30UTR WT or 2 mg pRLTK-NDUFV2 30UTR mutant.
The transfected neurons were analyzed for Renilla luciferase and firefly lucif-
erase using the dual luciferase assay system (Promega). The Renilla luciferase
values were normalized to the firefly luciferase activity levels, which accounts
for transfection efficiencies.
Metabolic Labeling
DIV6 cortical neurons were cultured in 100 mm plate for 30 min in methionine
and cysteine-free media (Invitrogen); 60 mCi 35S-methionine (ProMix, Amer-
sham) was then added and the cells were cultured for 1 hr. The cells were lysed
in 1 ml of 50 mM Tris-HCl [pH 8], 150 mM sodium chloride, 1% NP-40, 0.5%798 Cell Metabolism 16, 789–800, December 5, 2012 ª2012 Elseviersodium deoxycholate, 0.1% SDS, and protease inhibitors. Lysates from
WT and CPEB1 KO cells containing equivalent counts of radioactivity were
then added to NDUFV2-protein A bead mixture, which was rotated overnight
at 4C. The beads were washed and analyzed by electrophoresis and
phosphorimaging.
PAT Assay
For analysis of the poly(A) tail of the NDUFV2 mRNA, 10 mg of total RNA was
extracted from brain using Trizol reagent (Invitrogen) and following the manu-
facturer’s instructions. The RNA was annealed to oligo d(T) anchor (200 ng/ml;
50-GCGAGCTCCGCGGCCGCGTTTTTTTTTTTT-30) at 65C for 5 min and then
extended in a cDNA synthesis reaction using Superscript III (Invitrogen) at
50C for 60 min according to manufacturer’s instructions. cDNA template
(1 ml) along with NDUFV2-specific primer and oligo d(T)anchor were used in
a 25 ml PCR reaction with GoTaq (Invitrogen). PCR products were analyzed
on 2.5% agarose gels.
Quantification of Dendritic Growth
Hippocampal neurons grown on coverslips were fixed in 4% paraformalde-
hyde in PBS containing 4% sucrose for 20 min at room temperature at various
DIV. Coverslips were washed in PBS, permeabilized in 0.2% Triton X-100 for
7 min, blocked in 10% BSA solution, and immunostained with anti-alpha
tubulin (Sigma, 1:1000 dilution). The neurons were then imaged using Nikon
ECLIPSE E600 fluorescence microscope. The length of branches was calcu-
lated by tracing the dendrites in NeuronJ (plugin in ImageJ) software. The
amount of branching was determined using the Sholl analysis plugin in
ImageJ (NIH) software. Other neurons were supplemented daily with 1 mM
phosphocreatine on DIV 2, 3, 4, and 5 before performing Sholl analysis
on DIV 6.
Construction, Production, and Stereotactic Injection of Engineered
Retroviruses
Engineered self-inactivating murine retroviruses were used to express GFP
specifically in proliferating cells and their progeny. GFP expression was under
the control of the eEF1a promoter, and the shRNA was coexpressed under the
control of the human U6 promoter in the same vector. shRNA against mouse
CPEB1 (position 1,466, gtcgtgtgactttcaataa) was cloned into a retroviral vector
using a PCR SHAGing strategy. Adult (7–8 weeks old) female C57Bl/6 mice
(Charles River) housed under standard conditions were anaesthetized
(100 mg ketamine, 10 mg xylazine in 10 ml saline per gram), and retroviruses
were stereotactically injected into the DGs as previously described (Ge
et al., 2006). Mice were sacrificed at 14 days postinfection (dpi) for morpholog-
ical analysis. Images were acquired on a Carl Zeiss LSM 710 confocal system
and analyzed using Carl Zeiss Zen software. For analysis of the dendritic struc-
ture of neurons, the images were semiautomatically traced with NIH ImageJ
using the NeuronJ plugin. Only granule cells with complete dendritic trees
that were not overlapping with the other infected neurons were used for
morphological characterization (neurons from four to six animals per condition
were examined). The Sholl analysis for dendritic complexity was carried out by
counting the number of dendrites that cross a series of concentric circles at
20 mm intervals from the soma. For ectopic expression of NDUVF2, a retroviral
construct encoding for NDUVF2 fused to mCherry via a T2A linker was used
(Szymczak et al., 2004). To determine whether NDUFV2 expression can rescue
the dendritic branching dysfunction in the CPEB1-deficient neurons in vivo,
mouse DGs were stereotactically injected with either of three groups of retro-
viruses: group 1 contained viruses expressing shRNA for CPEB1 andmcherry,
group 2 contained viruses expressing shRNA for CPEB1 andWTNDUFV2, and
group 3 contained viruses expressing shRNA for CPEB1 and NDUFV2 that
lacked its MTS. The neurons were then analyzed as described above. Statis-
tical significance (p < 0.001) was determined by one-way ANOVA with New-
man-Keuls’ post hoc test. All animal procedures and applicable regulations
of animal welfare were in accordance with the IACUC guidelines and were
approved by Singhealth IACUC in Singapore.
Statistical Analysis
Data were interpreted using Students t test, and the error bars indicate stan-
dard error of the mean (SEM). Statistical significance was determined by
one-way ANOVA with Newman-Keuls’ post hoc test.Inc.
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